(Q37957033)

25 August 2017

title

Vaccines and immunomodulatory therapies for food allergy (English)

1 reference

25 August 2017

2

Anna Nowak-Węgrzyn

1 reference

25 August 2017

Jay A Lieberman

1

1 reference

25 August 2017

publication date

1 February 2012

1 reference

Current Allergy and Asthma Reports

25 August 2017

published in

1 reference

25 August 2017

volume

12

1 reference

25 August 2017

issue

1

1 reference

25 August 2017

page(s)

55-63

1 reference

Food allergy among children in the United States

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Treatment of peanut allergy with rush immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Oral desensitizing treatment in food allergy: clinical and immunological results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Egg oral immunotherapy in nonanaphylactic children with egg allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Open-label maintenance after milk oral immunotherapy for IgE-mediated cow's milk allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Clinical efficacy and immune regulation with peanut oral immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Successful oral tolerance induction in severe peanut allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Oral peanut immunotherapy in children with peanut anaphylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Tolerance to extensively heated milk in children with cow's milk allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Immunologic changes in children with egg allergy ingesting extensively heated egg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Severe anaphylaxis to kiwi fruit: Immunologic changes related to successful sublingual allergen immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Characterization of the T-cell epitopes of a major peanut allergen, Ara h 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Novel T-cell epitopes of ovalbumin in BALB/c mouse: potential for peptide-immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Ara h 2 peptides containing dominant CD4+ T-cell epitopes: candidates for a peanut allergy therapeutic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Ara h 1-reactive T cells in individuals with peanut allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Engineering, characterization and in vitro efficacy of the major peanut allergens for use in immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Mutational analysis of major, sequential IgE-binding epitopes in alpha s1-casein, a major cow's milk allergen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

A recombinant hypoallergenic parvalbumin mutant for immunotherapy of IgE-mediated fish allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

A mutant of the major apple allergen, Mal d 1, demonstrating hypo-allergenicity in the target organ by double-blind placebo-controlled food challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Oral tolerance to food-induced systemic anaphylaxis mediated by the C-type lectin SIGNR1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Allergen immunotherapy with heat-killed Listeria monocytogenes alleviates peanut and food-induced anaphylaxis in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Persistent protective effect of heat-killed Escherichia coli producing "engineered," recombinant peanut proteins in a murine model of peanut allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Allergy therapy by intranasal administration with recombinant Lactococcus lactis Producing bovine beta-lactoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

The immunologic effect of TGF-beta1 chitosan nanoparticle plasmids on ovalbumin-induced allergic BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Effect of anti-IgE therapy in patients with peanut allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Food Allergy Herbal Formula-1 (FAHF-1) blocks peanut-induced anaphylaxis in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Food Allergy Herbal Formula-2 silences peanut-induced anaphylaxis for a prolonged posttreatment period via IFN-gamma-producing CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Safety, tolerability, and immunologic effects of a food allergy herbal formula in food allergic individuals: a randomized, double-blinded, placebo-controlled, dose escalation, phase 1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Efficacy, safety and immunological actions of butanol-extracted Food Allergy Herbal Formula-2 on peanut anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Chronic helminth infections protect against allergic diseases by active regulatory processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Trichuris suis ova therapy for allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

An enteric helminth infection protects against an allergic response to dietary antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Trichuris suis therapy in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Specific oral tolerance induction in children with very severe cow's milk–induced reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0232-5

Protein unfolding strongly modulates the allergenicity and immunogenicity of Pru p 3, the major peach allergen

21 January 2018

1 reference

12 December 2020

Sublingual immunotherapy for cow's milk protein allergy: a preliminary report

1 reference

12 December 2020

Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization

1 reference

12 December 2020

A protocol for oral desensitization in children with IgE-mediated cow's milk allergy

1 reference

12 December 2020

Food allergy in children: results of a standardized protocol for oral desensitization.

1 reference

12 December 2020

Multiple T cell epitope peptides suppress allergic responses in an egg allergy mouse model by the elicitation of forkhead box transcription factor 3- and transforming growth factor-beta-associated mechanisms

1 reference

12 December 2020

Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction

1 reference

12 December 2020

Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract

1 reference

12 December 2020

Cow's milk epicutaneous immunotherapy in children: a pilot trial of safety, acceptability, and impact on allergic reactivity

1 reference

12 December 2020

Engineered recombinant ovomucoid third domain can desensitize Balb/c mice of egg allergy

1 reference

12 December 2020

Individualized IgE-based dosing of egg oral immunotherapy and the development of tolerance.

1 reference

12 December 2020

Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract

1 reference

12 December 2020

Oral immunotherapy for cow's milk allergy with a weekly up-dosing regimen: a randomized single-blind controlled study

1 reference

12 December 2020

Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract

1 reference

12 December 2020

Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial

1 reference

12 December 2020

10.1007/S11882-011-0232-5

Identifiers

DOI

1 reference

25 August 2017

1 reference